๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
NCT06879145Muscular Invasive Bladder Cancer (MIBC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3
840
Shanghai
2025-04-25
Recruiting
Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging
NCT06945549Inflammatory Bowel Disease (IBD), Disease Activity, FAPI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Observational
30
Chongqing
2025-04-25
Recruiting
Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke
NCT06943885Acute Ischemic Stroke
Beijing Emergency Medical Center
Not applicable
952
Beijing
2025-04-25
Recruiting
iTBS for Acute Ischemic Stroke After Thrombectomy
NCT06941961Ischemic Stroke
Yi Yang
Not applicable
178
Changchun
2025-04-25
Recruiting
Study on Multi-Modality Models of Cardiac Function in Healthy Individuals
NCT06952673Healthy Volunteers Only
Shanghai Ruiwei Digital Technology Co. Ltd.
Not applicable
270
Shanghai
2025-04-25
Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1/2
146
Beijing, Guangzhou, Nanjing, Shanghai
2025-04-25
Recruiting
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
NCT06934447CAR T Cell Therapy, Systemic Lupus Erythematosus, BCMA
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
18
Hangzhou
2025-04-25
Active, closed
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema๏ผˆDME๏ผ‰
NCT06908876Diabetic Macular Oedema
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase 2
150
Shanghai
2025-04-24
Recruiting
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
NCT06898255Cancer Cachexia
Genfleet Therapeutics (Shanghai) Inc.
Phase 1
36
Guangzhou
2025-04-24
Recruiting
A Study of BR111 in Patients With Advanced Malignancies
NCT06937957Advanced Malignancies
BioRay Pharmaceutical Co., Ltd.
Phase 1
166
Shanghai
2025-04-24
Recruiting
A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors
NCT06922357Advanced/Metastatic Solid Tumors
Shandong Suncadia Medicine Co., Ltd.
Phase 1/2
120
Harbin, Hangzhou
2025-04-24
By invitation
A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
NCT06999941Psoriasis, Eczema, JAK Inhibitor
Xi Tan
Observational
50
Shanghai
2025-04-24
Recruiting
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06830499AORTIC VALVE DISEASES, Bicuspid Aortic Valve (BAV)
Xijing Hospital
Observational
450
Xi'an, Chengdu, Beijing, Shanghai
2025-04-24
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
NCT06875310Carcinoma, Non-Small-Cell Lung
Mirati Therapeutics Inc.
Phase 3
630
Bengbu, Hefei, Beijing, Chongqing, Fuzhou Fujian, Xiamen, Guangzhou, Shantou
2025-04-24
Recruiting
A Phase I Study of SIM0388 in Participants With Malignant Ascites.
NCT07007988Malignant Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
50
Shanghai
2025-04-24
Recruiting
A Trial of HRS-6768 in Patients With Advanced Solid Tumors
NCT06925581Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
84
Beijing, Shanghai
2025-04-24
Recruiting
GR1803 Injection in Patients With RRMM
NCT06952075Multiple Myleoma
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 2
30
Tianjin
2025-04-24
By invitation
Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients
NCT06908473Metabolic Syndrome, Cardiovascular Disease (CKD), Cerebrovascular Disease, Qi Deficiency and Blood Stasis
Guangdong Provincial Hospital of Traditional Chinese Medicine
Phase 3
530
Guangzhou
2025-04-24
Recruiting
Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery
NCT07062952Kidney Tumors, CKD, Salt Substitute, Nephrectomy
Jinling Hospital, China
Not applicable
200
Nanjing
2025-04-24
Recruiting
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07140328Chronic Obstructive Lung Disease (COLD)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
50
Nanchang
2025-04-24
Recruiting
Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis
NCT06968520Head and Neck Tumors, Metal, Copper, Radiotherapy-Induced Oral Mucositis
Nanfang Hospital, Southern Medical University
Observational
383
Guangzhou
2025-04-24
Recruiting
VA Dual Sequential Therapy
NCT06929962Helicobacter Pylori Infection
The First Affiliated Hospital with Nanjing Medical University
Phase 4
600
Nanjing
2025-04-24
Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
NCT06880770Severe Hypertriglyceridemia
Arrowhead Pharmaceuticals
Phase 3
288
Beijing, Guangzhou, Guiyang, Harbin, Luoyang, Nanyang, Zhuzhou, Baotou
2025-04-24
Active, closed
Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma
NCT07047001Renal Cell Carcinoma (RCC), Adjuvant
Dong Wen
Phase 2
60
Guangzhou
2025-04-24
Recruiting
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
NCT06929624Diffuse Large B-cell Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
280
Beijing, Guangzhou
2025-04-24
Recruiting
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
NCT06885385Advanced Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
60
Beijing, Shanghai
2025-04-23
Active, closed
Combined Cyclic Compression Cryotherapy and Phased Rehabilitation Training for Recovery After Knee Replacement
NCT07089212Knee Arthroplasty, Total, Rehabilitation Therapy
Qilu Hospital of Shandong University
Not applicable
100
Jinan
2025-04-23
Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
NCT06827236Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer
BioNTech SE
Phase 1/2
380
Bengbu, Changchun, Chengdu, Chongqing, Huizhou, Nanning, Shanghai, Xi'an
2025-04-23
Recruiting
BCI-Assisted SCS-EXS for Gait Optimization
NCT06939660Spinal Cord Injuries (SCI), Spinal Cord Injury, Chronic, Spinal Cord Injury, Spinal Cord Injury Cervical
Xuanwu Hospital, Beijing
Not applicable
3
Beijing
2025-04-23
Recruiting
Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
NCT06829771Diffuse Large B Cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
90
Bengbu, Maโ€™anshan, Beijing, Fuzhou, Quanzhou, Lanzhou, Guangzhou, Liuzhou
2025-04-23
By invitation
Intrapatient Comparison of STN and GPi tTIS in PD
NCT07018388Parkinson Disease
Ruijin Hospital
Not applicable
100
Shanghai
2025-04-23
Recruiting
Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR
NCT06711016Cardiac Arrest
Qilu Hospital of Shandong University
Not applicable
654
Jinan
2025-04-22
Recruiting
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545Coronary Artery Disease, CT Angiography, PCSK9, Cardiovascular Events
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
3,596
Hangzhou, Jinhua
2025-04-22
By invitation
Healthy Adult Reference Biobank for Cardiovascular Biomarkers in China
NCT07136675Healthy Individuals (Controls)
China National Center for Cardiovascular Diseases
Observational
2,400
Beijing
2025-04-22
Recruiting
A Phase IIa Study to Evaluate NBQ72S
NCT06810804Breast Cancer
Nantong Bencao Quadriga Medical Technology Co. Ltd.
Phase 2
10
Beijing
2025-04-22
Active, closed
Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects
NCT07024212MASLD
Zhejiang Doer Biologics Co., Ltd.
Phase 2
110
Hangzhou, Changchun, Nanjing
2025-04-22
Active, closed
Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT07117760Prostate Cancer
First Affiliated Hospital of Fujian Medical University
Phase 1/2
16
Fuzhou
2025-04-22
Recruiting
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06857279Carcinoma of Head and/or Neck
Shanghai Henlius Biotech
Phase 2
167
Jinan, Shanghai
2025-04-22
Recruiting
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
NCT06902896Dilated Cardiomyopathy (DCM), Heart Failure
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
43
Hangzhou
2025-04-22
Not yet open
Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
NCT06922916COPD, Interstitial Pneumonia, Bronchiectasis, Respiratory Failure
Zhejiang University
Observational
250
Hangzhou
2025-04-22
Recruiting
Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery
NCT07081919Corneal Astigmatism, Cataract
Eye & ENT Hospital of Fudan University
Observational
105
Shanghai
2025-04-22
By invitation
Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
NCT06737354nAMD
InnoVec Biotherapeutics Inc.
Phase 1
18
Chengdu
2025-04-22
By invitation
Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab
NCT06719921Atrial Fibrillation (AF)
Sir Run Run Shaw Hospital
Not applicable
724
Hangzhou
2025-04-22
Recruiting
NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial
NCT07077551NENS
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
28
Hangzhou
2025-04-22
Active, closed
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects
NCT06485245MASH
Cascade Pharmaceuticals, Inc
Phase 1
80
Beijing
2025-04-22
Recruiting
A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease
NCT06900010Autoimmune Bullous Disease
Shandong First Medical University
Phase 2
30
Jinan
2025-04-22
Recruiting
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
NCT06987916B Cell Lymphoma
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase 1/2
50
Shanghai
2025-04-22
Recruiting
Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
NCT07025590Cardiovascular Diseases (CVD), Depression Anxiety Disorder
Guangdong Provincial People's Hospital
Not applicable
106
Guangzhou
2025-04-22
Recruiting
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
NCT06850103Colorectal Carcinoma, Oligometastases, pMMR, MSS
First Affiliated Hospital of Zhejiang University
Phase 2
51
Hangzhou
2025-04-22
Recruiting
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
NCT07128186Cognitive Dysfunction
Tongji Hospital
Observational
5,000
Enshi, Huanggang, Huangshi, Jingzhou, Shiyan, Suizhou, Wuhan, Xiangyang
2025-04-22
Recruiting
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
NCT07131319Non-Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University
Phase 2/3
30
Nanchang
2025-04-21
Recruiting
a Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors
NCT06878612Polyphenols, Cancer Vaccine, Advanced Solid Tumor
Xingchen Peng
Phase 1
9
Chengdu
2025-04-21
Recruiting
Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease
NCT07653711End Stage Renal Disease on Dialysis
Peking University People's Hospital
Not applicable
30
Beijing
2025-04-21
By invitation
A Study Evaluating the Efficacy of Endoscope Ethmoid Infundibulum Expansion Surgery (EEIES) Combined With Stapokibart in the Treatment of Type 2 Chronic Rhinosinusitis
NCT07073664Chronic Sinusitis
China-Japan Union Hospital
Not applicable
30
Changchun
2025-04-21
By invitation
Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke Patients Receiving Reperfusion Treatment
NCT06848894Acute Ischemic Stroke
Beijing Tiantan Hospital
Not applicable
1,204
Beijing
2025-04-21
Recruiting
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
NCT07235566Thyroid Cancer
Fudan University
Phase 2
60
Shanghai
2025-04-21
Recruiting
Different Injection Speed on Local Anaesthetic Spread of ESPB
NCT06936904Erector Spinae Plane Block
Nanjing First Hospital, Nanjing Medical University
Not applicable
74
Nanjing
2025-04-21
Recruiting
Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders
NCT06896279Disorder of Consciousness, Temporal Interference Stimulation
Huashan Hospital
Not applicable
20
Shanghai
2025-04-21
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
National University of Singapore
Phase 4
600
Hangzhou, Xi'an, Xuzhou
2025-04-21
Recruiting
RGL-305+ Lymphoma + Exploratory Clinical Study
NCT07006012Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Fudan University
Not applicable
12
Shanghai
2025-04-21
Recruiting
The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.
NCT06984731Cardiovascular Diseases, Arrhythmia
Affiliated Hospital of Nantong University
Observational
210
Nantong
2025-04-21
Recruiting
A Study on the Application of NE Irrigation Fluid for Hemostasis in Flexible Ureteroscopic Lithotripsy: A Prospective Single-arm Interventional Study of Upper Urinary Tract Calculi.(NE: Norepinephrine)
NCT07786844Urolithiasis, Lithotripsy
Geriatric Hospital of Nanjing Medical University
Phase 1/2
55
Nanjing
2025-04-21
Recruiting
Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer
NCT06934018Oncology, Tumor Recurrence and Metastasis
Fudan University
Not applicable
140
Shanghai
2025-04-21
Recruiting
TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
NCT06914297Endometrial Cancer
Fudan University
Phase 2
10
Shanghai
2025-04-21
Recruiting
The Effect of Situation Puzzle Games on Nursing Students' Death Anxiety and Meaning in Life
NCT06991621Death Anxiety
China Medical University, China
Not applicable
70
Shenyang
2025-04-21
By invitation
Breast Cancer PET/CT Imaging With 68Ga-pAKTi
NCT06943313Breast Cancers, PIK3CA Mutation-Related Tumors, PI3K Pathway Activated Tumors, PET / CT
Fudan University
Observational
20
Shanghai
2025-04-21
Recruiting
A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
NCT07022288Atopic Dermatitis of Face
ChinaNorm
Not applicable
76
Shanghai
2025-04-20
Recruiting
Validation of Five Seasons Sleep Tracking Mat for the Diagnosis of Obstructive Sleep Apnea
NCT06875479Obstructive Sleep Apnea (OSA)
Shanghai 6th People's Hospital
Observational
400
Shanghai
2025-04-20
Recruiting
Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
NCT07166003Lung Cancer, Non-Small Cell, Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
500
Beijing
2025-04-20
By invitation
VISOR Versus PCNL for Treatment of 2-4cm Renal Stones
NCT07159503Kidney Calculi, Kidney Stones
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
170
Hangzhou
2025-04-20
Active, closed
PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer
NCT06933251Locally Advanced Rectal Cancer (LARC)
Guangdong Provincial People's Hospital
Phase 2
30
Guangzhou
2025-04-20
Recruiting
Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
NCT06713720Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy, Remote Ischemic Conditioning, Diabetes Mellitus, Type 2
Xuxiang Zhang, MD
Not applicable
68
Beijing
2025-04-20
Active, closed
Effects of HIPEC on Postoperative Bowel Motility and Complications
NCT07353177HIPEC, Gastro Intestinal Cancer, Adhesion Prevention, Bowel Functions
Peking University People's Hospital
Observational
193
Beijing
2025-04-20
Recruiting
Cryoablation vs Thoracoscopic Surgery for GGN
NCT06848881Ground-Glass Opacity
Shanghai Chest Hospital
Not applicable
160
Shanghai
2025-04-20
By invitation
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196Psoriasis (PsO), Randomised Controlled Trial
Xijing Hospital
Phase 3
160
Xi'an
2025-04-20
Active, closed
Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy
NCT06947590HCM - Hypertrophic Cardiomyopathy, Mavacamten
Xu Liu
Not applicable
78
Shanghai
2025-04-20
Active, closed
Gamified Digital Balance Assessment
NCT07088848Disease Prevention
Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2025-04-20
Not yet open
Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer
NCT06941987Minimal Residual Disease, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
66
Shanghai
2025-04-20
Not yet open
Effects of Peginterferon Consolidation Therapy on Hepatic cccDNA Dynamics in CHB Patients Achieving Clinical Cure.
NCT06920329Chronic Hepatitis b
Xiamen Hospital of Traditional Chinese Medicine
Not applicable
30
Xiamen
2025-04-20
Recruiting
A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06356688Locally Advanced Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy
Sun Jing
Phase 2
30
Nanjing
2025-04-20
Recruiting
An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
NCT06936787Retinitis Pigmentosa
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 1
21
Shanghai
2025-04-20
Recruiting
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
NCT06935513Hypertension, Diabetes, Atrial Fibrillation, Dyslipidemia
Affiliated Hospital of Nantong University
Not applicable
300
Nantong
2025-04-20
Recruiting
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC๏ผˆARMOR2501๏ผ‰
NCT06924398Lung Cancer (NSCLC)
Sun Yat-sen University
Phase 2
32
Guangzhou
2025-04-20
Recruiting
Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
NCT07163910Prostate Cancer
baotai Liang
Phase 2
93
Nanjing
2025-04-20
Recruiting
A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
NCT06962267Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
50
Beijing
2025-04-18
Active, closed
Critical Closing Pressure and PCOโ‚‚ Gap in Fluid Resuscitation for Septic Shock
NCT07043192Septic Shock, Fluid Resuscitation, Tissue Perfusion Pressure, Carbon Dioxide Pressure
Peking Union Medical College
Observational
60
Beijing
2025-04-18
Recruiting
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
NCT06947460Refractory Lupus Nephritis, Systemic Sclerosis, Primary Sjogren's Syndrome Combined With Pulmonary Hypertension, Other Autoimmune Diseases (AID)
Beijing GoBroad Hospital
Phase 1/2
45
Beijing
2025-04-18
Recruiting
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
NCT06948981Hematological Malignancy (Leukemia- Lymphoma)
Grit Biotechnology
Phase 1/2
46
Tianjin
2025-04-18
Recruiting
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
NCT06974812Unresectable Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
250
Fuzhou, Changsha, Shanghai
2025-04-18
Recruiting
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
NCT06770439Advanced Pancreatic Cancers
Zhejiang University
Phase 2
64
Hangzhou
2025-04-18
Recruiting
Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases
NCT07134153Breast Cancer
Fudan University
Phase 1/2
139
Shanghai
2025-04-18
Recruiting
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06860971Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
144
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Gui'lin, Liuzhou
2025-04-18
Recruiting
FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis
NCT06801665Colorectal Cancer Liver Metastasis
Hua Jiang
Phase 2
30
Changzhou
2025-04-17
Active, closed
Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes
NCT06833723Breast Neoplasms
Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
Observational
1,000
Hangzhou
2025-04-17
Recruiting
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
NCT06935188Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
98
Shanghai
2025-04-17
Not yet open
GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma
NCT06605131Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
72
Guangzhou
2025-04-17
Recruiting
Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.
NCT07306988HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome
Nanjing First Hospital, Nanjing Medical University
Phase 4
120
Nanjing
2025-04-17
Recruiting
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
NCT07347171Leukemia, AML, MDS, AML (Acute Myelogenous Leukemia)
Cullgen (Shanghai),Inc
Phase 1
45
Nanchang, Tianjin, Wuhan
2025-04-17
Recruiting
Effectiveness of a Lifestyle Intervention for Pregnant Women With Abnormal Glucose Metabolism in Early Pregnancy: EAGM Trial
NCT06767722Early Pregnancy, Fasting Plasma Glucose, Hemoglobin A1c Protein, Human, Lifestyle Intervention
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
3,430
Guangzhou
2025-04-16
By invitation
Predicting the Metabolic Biomarkers Associated With Injury in Athletes
NCT06888635Sports Medicine
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2025-04-16
Rows per page Showing 8401–8500 of 19052
Previous 83 84 85 86 87 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=85

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.